# INZIRQO

NDC: 70954-522
Generic name: hydrochlorothiazide
Labeler / Manufacturer: ANI Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL
Marketing started: 20250130

FDA application: NDA219141

## Active ingredients

- HYDROCHLOROTHIAZIDE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70954-522"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70954-522
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41aaea48-6c1b-42c8-a96f-5923d49dc934